| [1] PubMed ID: | 40056302 |
| Disease Name: | Pancreatic Neoplasms |
| Tissue: | Pancreas |
| Dysfunction Pattern: | Down-Regulation |
| Validated Method: | PCR//Western blot//Cell apoptosis assay//Cell proliferation assay//Transwell assay//Luciferase reporter assay//Sequencing |
| Description: | TRF-Pro-CGG was significantly downregulated in PC tissues and cell lines compared to normal tissues and cells. Overexpression of tRF-Pro-CGG in SW1990 cells inhibited cell proliferation, clonality, migration, and invasion, while promoting apoptosis. Conversely, inhibition of tRF-Pro-CGG in PANC-1 cells had the opposite effects. |
| Comparision: | Cancer VS Normal |
| Mechanism: | Dual luciferase assays confirmed CSF1 as a direct target of tRF-Pro-CGG, and Western blot analysis showed that tRF-Pro-CGG negatively regulated CSF1 expression. Furthermore, tRF-Pro-CGG was found to modulate the PI3K-AKT signaling pathway, with downstream effects on key molecules such as AKT, P-AKT, and PTEN. |
|